Stocks › HQL
abrdn Life Sciences Investors
HQL·NYSE·
United States·USD
United States·USD$17.56
+0.00 (+0.00%)
Close · Oct 7, 2026 · Close Prices from Tiingo.com
HQL
abrdn Life Sciences Investors · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
HQLS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of HQL by members of U.S. Congress · 9 on record
Whale Activity
Position changes in HQL reported for 2026-06-30 by 2 tracked institutional filers
- Increased0
- New1
- Held0
- Decreased0
- Closed1
- No prior filing0
| Filer | Shares | Value | Change |
|---|---|---|---|
| CITADEL ADVISORS LLC | 14.4K | $287K | new |
| BlackRock, Inc. | 0 | $0 | closed |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by HQL insiders, by quarter · Form 4
Recent Insider Transactions
113 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Mahai Chris LaVictoireDirector · Director | Purchase | +527 | $19.92 | $10K | Jul 16, 2026 | Form 4 ↗ |
| Pittard ChristianDirector | Purchase | +7,923 | $16.88 | $134K | Dec 16, 2025 | Form 4 ↗ |
| Saba Capital Management, L.P.10% owner | Sale | −41.6K | $14.14 | $589K | Sep 22, 2025 | Form 4 ↗ |
| Saba Capital Management, L.P.10% owner | Sale | −6,989 | $14.10 | $99K | Sep 19, 2025 | Form 4 ↗ |
| Saba Capital Management, L.P.10% owner | Sale | −40.2K | $14.07 | $566K | Sep 18, 2025 | Form 4 ↗ |
| Saba Capital Management, L.P.10% owner | Sale | −24.3K | $13.99 | $340K | Sep 17, 2025 | Form 4 ↗ |
| Saba Capital Management, L.P.10% owner | Sale | −2,026 | $13.99 | $28K | Sep 16, 2025 | Form 4 ↗ |
| Saba Capital Management, L.P.10% owner | Sale | −700 | $14.13 | $10K | Sep 15, 2025 | Form 4 ↗ |
| Saba Capital Management, L.P.10% owner | Sale | −15.1K | $14.28 | $216K | Sep 11, 2025 | Form 4 ↗ |
| Weinstein Boaz10% owner | Sale | −14.1K | $14.04 | $198K | Sep 2, 2025 | Form 4 ↗ |
| Weinstein Boaz10% owner | Sale | −23.7K | $13.89 | $330K | Aug 29, 2025 | Form 4 ↗ |
| Saba Capital Management, L.P.10% owner | Sale | −400 | $13.83 | $6K | Aug 26, 2025 | Form 4 ↗ |
| Saba Capital Management, L.P.10% owner | Sale | −10.7K | $14.07 | $151K | Aug 21, 2025 | Form 4 ↗ |
| Weinstein Boaz10% owner | Sale | −11.4K | $12.71 | $145K | May 20, 2025 | Form 4 ↗ |
| Weinstein Boaz10% owner | Sale | −23.7K | $12.08 | $287K | May 15, 2025 | Form 4 ↗ |
| Saba Capital Management, L.P.10% owner | Sale | −600 | $12.04 | $7K | May 14, 2025 | Form 4 ↗ |
| Saba Capital Management, L.P.10% owner | Sale | −730 | $12.28 | $9K | May 13, 2025 | Form 4 ↗ |
| Saba Capital Management, L.P.10% owner | Sale | −12.7K | $11.98 | $152K | May 8, 2025 | Form 4 ↗ |
| Saba Capital Management, L.P.10% owner | Sale | −1,366 | $12.19 | $17K | May 7, 2025 | Form 4 ↗ |
| Weinstein Boaz10% owner | Sale | −9,144 | $11.78 | $108K | Apr 17, 2025 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding HQL · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| Amplify CEF High Income ETF Amplify ETF Trust | 834.9K | $16.7M | 2.32% | Jun 30, 2026 |
| RiverNorth Opportunities Fund Inc. | 150.0K | $3.0M | 0.91% | Jun 30, 2026 |
| Modern Capital Tactical Income Fund Modern Capital Funds Trust | 132.8K | $2.7M | 3.91% | Jun 30, 2026 |
| First Trust Income Opportunities ETF First Trust Exchange-Traded Fund VIII | 56.8K | $1.0M | 1.28% | May 31, 2026 |
| Saba Closed-End Funds ETF Exchange Listed Funds Trust | 46.0K | $821K | 0.19% | May 31, 2026 |
| Saba Capital Income & Opportunities Fund II | 24.8K | $434K | 0.17% | Apr 30, 2026 |
| Saba Capital Income & Opportunities Fund | 6,417 | $112K | 0.03% | Apr 30, 2026 |
| ABSOLUTE CEF OPPORTUNITIES UNIFIED SERIES TRUST | 1,812 | $29K | 0.52% | Mar 31, 2026 |
| Multi-Hedge Strategies Fund Rydex Variable Trust | 271 | $5K | 0.02% | Jun 30, 2026 |
| Guggenheim Multi-Hedge Strategies Fund Rydex Series Funds | 97 | $2K | 0.02% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list HQL's shares (CUSIP 87911K100), each fund at its latest report since Mar 8, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming abrdn Life Sciences Investors as client
No lobbying filings found naming abrdn Life Sciences Investors as the client.
Government Contracts
Federal awards to abrdn Life Sciences Investors · USAspending
No federal contract awards found for abrdn Life Sciences Investors.
U.S. Patents
Recent USPTO applications naming abrdn Life Sciences Investors
No USPTO patent applications found for abrdn Life Sciences Investors.
Annual Financials
From HQL's 10-K filings · XBRL
No annual XBRL figures on record for HQL. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in HQL's price history.
Material Events (8-K)
Corporate events filed with the SEC
No 8-K filings on record.
About abrdn Life Sciences Investors
From SEC EDGAR company records
HeadquartersPHILADELPHIA, PA
IncorporatedMA
SEC CIK0000884121 ↗
Former namesTEKLA LIFE SCIENCES INVESTORS, H&Q LIFE SCIENCES INVESTORS